Current therapies and new developments in NASH
10.1136/gutjnl-2021-326874
June 16, 2022
GUT Recent advances in clinical practice
COVID-19 and liver disease
10.1136/gutjnl-2021-326792
June 14, 2022
Artificial intelligence in gastroenterology and hepatology: how to advance clinical practice while ensuring health equity
10.1136/gutjnl-2021-326271
June 10, 2022
Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic
10.1136/gutjnl-2021-326784
April 27, 2022
Cross-roads for meta-analysis and network meta-analysis of therapy
10.1136/gutjnl-2021-326170
November 8, 2021
Novel therapeutic targets for cholestatic and fatty liver disease
10.1136/gutjnl-2021-324305
October 6, 2021
What to do about the leaky gut
10.1136/gutjnl-2021-325428
September 11, 2021
Alternative treatments for type 2 diabetes and associated metabolic diseases: medical therapy or endoscopic duodenal mucosal remodelling?
10.1136/gutjnl-2020-323931
September 8, 2021
Dietary fibres and IBS: translating functional characteristics to clinical value in the era of personalised medicine
10.1136/gutjnl-2021-324891
August 20, 2021
Recent advances in clinical practice: epidemiology of autoimmune liver diseases
10.1136/gutjnl-2020-322362
July 15, 2021